The Trump administration must loosen communist China’s grip on drug manufacturing to protect American national security interests, RX Border Defense told Breitbart News Washington Bureau Chief Matthew Boyle on Thursday during an event on the threat of China.
Board members Raul Lopez and Patsy Writesman discussed how the U.S. Food and Drug Administration (FDA) has put many Chinese drug companies on a “Green List,” which means they are “not being detained at the border.”
They contend the government-created loophole allows China to flood the market with drugs that may have been created under lax safety standards, while also giving China the power…
Read the full article at BREITBART.COM
